Differences by medical specialty in prescribing weight-loss drugs for obese teens in Saudi Arabia

Real-world evidence on glucagon-like peptide-1 receptor agonists for adolescent obesity in Saudi Arabia is limited.

• Current usage of GLP-1 receptor agonists among adolescents indicates a need for further characterization.
• Variation in prescribing practices by specialty suggests differing approaches to treatment.
• Healthcare professionals identified barriers to prescribing, including training needs and lack of clinical guidance.

Simplified